CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
CTT PHARMACEUTICAL HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Sep 17, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026
- Market cap
- $1.26M
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Sep 30, 2015
Ctt Pharmaceutical reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Ctt Pharmaceutical's annual report. Trading prices and yields need FINRA TRACE data.